Prices of medicines and scheduled substances will only be adjusted by a maximum of 4.53% in 2020, health minister Zweli Mkhize announced in a notice published in the government gazette last week.
Medicine prices in the private sector are tightly controlled by the health department, which usually permits one increase a year on the ceiling price for each drug, known as the single exit price. The capped prices mean companies cannot pass on increased input costs to consumers, and thus face a squeeze on their profits...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.